Skip to main content
Erschienen in: Arthritis Research & Therapy 5/2005

01.09.2005 | Commentary

Clinical and laboratory characteristics of drug-induced vasculitic syndromes

verfasst von: Allan Wiik

Erschienen in: Arthritis Research & Therapy | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to spontaneous recovery, meaning that immunosuppressive therapy can be avoided. The presence of myeloperoxidase–antineutrophil cytoplasmic antibodies, IgM anticardiolipin antibody, and antihistone antibodies in combination was found to be characteristic of drug-induced vasculitic syndromes caused by the antithyroid drugs propylthiouracil and methimazol. Clinically, skin vasculitis and arthralgias predominated and renal vasculitis was rare.
Literatur
1.
Zurück zum Zitat Bonaci-Nikolic BM, Nikolic MM, Andrejevic S, Zoric S, Bukilica M: Antineutrophil cytoplasmic antibodies (ANCA)-associated autoimmune diseases induced by antithyroid drugs: Comparison with idiopathic vasculitides. Arthritis Res Ther. 2005, 7: R1072-R1081. 10.1186/ar1789.PubMedCentralCrossRefPubMed Bonaci-Nikolic BM, Nikolic MM, Andrejevic S, Zoric S, Bukilica M: Antineutrophil cytoplasmic antibodies (ANCA)-associated autoimmune diseases induced by antithyroid drugs: Comparison with idiopathic vasculitides. Arthritis Res Ther. 2005, 7: R1072-R1081. 10.1186/ar1789.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Roubey RAS: Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid autoantibodies'. Blood. 1994, 84: 2854-2867.PubMed Roubey RAS: Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid autoantibodies'. Blood. 1994, 84: 2854-2867.PubMed
3.
Zurück zum Zitat Thong HY, Chu CY, Chiu HC: Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous lupus erythematosus. Acta Dermatol Venereol. 2002, 208: 206-208. 10.1080/00015550260132523.CrossRef Thong HY, Chu CY, Chiu HC: Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous lupus erythematosus. Acta Dermatol Venereol. 2002, 208: 206-208. 10.1080/00015550260132523.CrossRef
4.
Zurück zum Zitat Choi HK, Merkel PA, Walker AM, Niles JL: Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000, 43: 405-413. 10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5.CrossRefPubMed Choi HK, Merkel PA, Walker AM, Niles JL: Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000, 43: 405-413. 10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5.CrossRefPubMed
5.
Zurück zum Zitat Kitahara T, Hiromura K, Maesawa A, Ono K, Narabara N, Yano S, Naruse T, Takenouchi K, Yasumoto Y: Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin Nephrol. 1997, 47: 336-340.PubMed Kitahara T, Hiromura K, Maesawa A, Ono K, Narabara N, Yano S, Naruse T, Takenouchi K, Yasumoto Y: Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin Nephrol. 1997, 47: 336-340.PubMed
6.
Zurück zum Zitat Rubin RL: Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs. Clin Biochem. 1992, 25: 223-234. 10.1016/0009-9120(92)90354-U.CrossRefPubMed Rubin RL: Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs. Clin Biochem. 1992, 25: 223-234. 10.1016/0009-9120(92)90354-U.CrossRefPubMed
7.
Zurück zum Zitat Herlin T, Birkebaek NH, Wolthers OD, Heegaard NH, Wiik A: Antineutrophil cytoplasmic antibodies (ANCA) prophiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism. Scand J Rheumatol. 2002, 31: 46-49. 10.1080/030097402317255381.CrossRefPubMed Herlin T, Birkebaek NH, Wolthers OD, Heegaard NH, Wiik A: Antineutrophil cytoplasmic antibodies (ANCA) prophiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism. Scand J Rheumatol. 2002, 31: 46-49. 10.1080/030097402317255381.CrossRefPubMed
Metadaten
Titel
Clinical and laboratory characteristics of drug-induced vasculitic syndromes
verfasst von
Allan Wiik
Publikationsdatum
01.09.2005
Verlag
BioMed Central
Erschienen in
Arthritis Research & Therapy / Ausgabe 5/2005
Elektronische ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1805

Weitere Artikel der Ausgabe 5/2005

Arthritis Research & Therapy 5/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.